Anaplastic Thyroid Cancer: The Addition of Systemic Chemotherapy to Radiotherapy Led to an Observed Improvement in Survival—A Single Centre Experience and Review of the Literature
Introduction. Anaplastic thyroid carcinoma (ATC) is rare yet accounts for up to 50% of all thyroid cancer deaths. This study reviews outcomes of patients with confirmed ATC referred to a tertiary oncology centre plus reviews the literature to explore how poor outcomes may be improved. Materials and...
Main Authors: | Natalie M. Lowe, Sean Loughran, Nicholas J. Slevin, Beng K. Yap |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2014/674583 |
Similar Items
-
Combined chemotherapy and irradiation in anaplastic thyroid carcinoma
by: Pejčić Ivica, et al.
Published: (2003-01-01) -
Evidence from an updated meta-analysis of the prognostic impacts of postoperative radiotherapy and chemotherapy in patients with anaplastic thyroid carcinoma
by: Xia Q, et al.
Published: (2018-04-01) -
Hypofractionated Radiotherapy for Anaplastic Thyroid Cancer: Systematic Review and Pooled Analysis
by: Dmytro Oliinyk, et al.
Published: (2020-09-01) -
Short Course High Dose Radiotherapy in the Treatment of Anaplastic Thyroid Carcinoma
by: Mark J. Stavas, et al.
Published: (2014-01-01) -
The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer
by: Denaro N, et al.
Published: (2013-09-01)